Health Care [ 3/12 ] | Health Care Technology [ 11/74 ]
NASDAQ | Common Stock
Veradigm Inc., a healthcare technology company, provides information technology solutions to healthcare providers, payers, and biopharma markets in the United States and internationally.
The company offers solutions to healthcare providers, comprising practice management software, AI patient scheduling software, and electronic statements and payments, and payerpath clearinghouse; revenue cycle services and coding services; electronic health records solutions, which include eprescribe with EPCS, EHR software, veradigm EHR, and practice fusion EHR; and patient engagement platform.
It also provides solutions to network partners, which comprise API connectivity solutions, such as veradigm connect, veradigm app expo, and diagnostic ordering and resulting network; life sciences, health plans and payers, and providers; and veradigm eprescribe enterprise.
In addition, the company offers risk adjustment solutions, such as health equity analytics, risk adjustment analytics, risk mitigator, comprehensive submissions, and utilization analytics; quality analytics, risk adjustment, and quality management; data exchange and coding solutions, including echart courier, echart coder, and echart integration and analytics; clinical data registries for physicians and veradigm payer insights; provider engagement solutions; care gap alerting, gap closure services, and veradigm payerpath solutions.
Further, it provides solutions, including real world data solutions, such as NLP-enriched EHR data solutions, and clinical data registries; real world evidence and real-world evidence analytics platform; and digital health media solutions.
The company was formerly known as Allscripts Healthcare Solutions, Inc. and changed its name to Veradigm Inc. in January 2023.
Veradigm Inc. was founded in 1986 and is headquartered in Chicago, Illinois.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| May 3, 24 | 0.00 Decreased by -100.00% | 0.54 Decreased by -100.00% |
| Mar 13, 24 | 0.00 Decreased by -100.00% | 0.33 Decreased by -100.00% |
| Oct 20, 23 | 0.21 Decreased by -6.52% | 0.28 Decreased by -23.32% |
| Sep 29, 23 | 0.26 Increased by +46.11% | 0.20 Increased by +28.80% |
| May 10, 23 | 0.16 Increased by +23.08% | 0.27 Decreased by -40.74% |
| Mar 1, 23 | 0.27 Decreased by -65.82% | 0.27 |
| Nov 3, 22 | 0.23 Decreased by -14.81% | 0.19 Increased by +21.05% |
| Aug 4, 22 | 0.18 Decreased by -21.74% | 0.15 Increased by +20.00% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Sep 30, 22 | 151.90 M Decreased by -58.86% | 11.00 M Decreased by -31.68% | Increased by +7.24% Increased by +66.06% |
| Jun 30, 22 | 150.90 M Decreased by -59.62% | 3.20 M Decreased by -85.41% | Increased by +2.12% Decreased by -63.86% |
| Mar 31, 22 | 142.70 M Decreased by -61.26% | 22.90 M Increased by +152.84% | Increased by +16.05% Increased by +552.66% |
| Dec 31, 21 | 391.70 M Increased by +41.03% | 87.30 M Decreased by -88.01% | Increased by +22.29% Decreased by -91.50% |
| Sep 30, 21 | 369.20 M Decreased by -8.18% | 16.10 M Increased by +3.12 K% | Increased by +4.36% Increased by +3.41 K% |
| Jun 30, 21 | 373.71 M Decreased by -8.00% | 21.93 M Increased by +388.31% | Increased by +5.87% Increased by +413.39% |
| Mar 31, 21 | 368.35 M Decreased by -11.60% | 9.06 M Increased by +144.40% | Increased by +2.46% Increased by +150.22% |
| Dec 31, 20 | 277.73 M Decreased by -38.42% | 727.82 M Increased by +3.93 K% | Increased by +262.06% Increased by +6.32 K% |